BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Vitro Diagnostics (VODG) Launches New Stem Cell Products for Clinical Use & Presents Webinar with HemoGenix Inc.


7/20/2011 8:30:22 AM

GOLDEN, Colo.--(BUSINESS WIRE)--Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced the commercial launch of several new stem cell products including those with application to clinical studies. The new products were presented to the scientific community in a webinar jointly produced with our strategic partner, HemoGenix®, Inc. entitled “Mesenchymal Stem/Stromal Cells: Advances in Assays and Growth/Differentiation Media.” Vitro’s catalog now consists of adult stem cells, their fluorescent derivatives, and an expanded menu of tools for cellular reprogramming of adult cells to the functional equivalent of embryonic stem cells. Vitro now offers several additional formulations of its highly competitive MSCGro™ stem cell media product line together with advanced analytical tools, jointly manufactured with HemoGenix®, Inc., for the determination of stem cell quality, potency and response to toxic agents.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES